{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:37:32Z","timestamp":1792460252652,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.mayocp.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T18:31:34Z","timestamp":1460658694000},"page":"812-819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions"],"prefix":"10.1016","volume":"91","author":[{"given":"Rachele","family":"Ciccocioppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gallia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Avanzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Betti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Picone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Paganini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Maccario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino R.","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000369519","article-title":"Refractory coeliac disease: epidemiology and clinical manifestations","volume":"33","author":"Malamut","year":"2015","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mayocp.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000369521","article-title":"Interleukin-15, a masterpiece in the immunological jigsaw of celiac disease","volume":"33","author":"Meresse","year":"2015","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000381076","article-title":"Therapy in RCDII: rationale for combination strategies?","volume":"33","author":"Nijeboer","year":"2015","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac with aberrant T-cells","volume":"109","author":"Al-Toma","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mayocp.2016.03.001_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.mayocp.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"issue":"9","key":"10.1016\/j.mayocp.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3324\/haematol.11446","article-title":"No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients","volume":"92","author":"Sundin","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.mayocp.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","volume":"12","author":"De Miguel","year":"2012","journal-title":"Curr Mol Med"},{"issue":"9624","key":"10.1016\/j.mayocp.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mayocp.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.mayocp.2012.04.014","article-title":"Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathy","volume":"87","author":"Ciccocioppo","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.mayocp.2016.03.001_bib12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","article-title":"Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease","volume":"34","author":"vanWanrooij","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.mayocp.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jcp.20911","article-title":"Optimization of in\u00a0vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute","volume":"211","author":"Bernardo","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.mayocp.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.mayocp.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00018-014-1797-7","article-title":"Are stem cells a potential therapeutic tool in coeliac disease?","volume":"72","author":"Ciccocioppo","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.mayocp.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcyt.2014.03.002","article-title":"Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease","volume":"16","author":"Ciccocioppo","year":"2014","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10637-010-9534-z","article-title":"Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts","volume":"30","author":"Secchiero","year":"2012","journal-title":"Invest New Drugs"},{"issue":"9071","key":"10.1016\/j.mayocp.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(97)01042-8","article-title":"Autoimmune enteropathy and villous atrophy in adults","volume":"350","author":"Corazza","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.mayocp.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","article-title":"Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses","volume":"136","author":"Gonzalez","year":"2009","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.mayocp.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1582-4934.2010.01151.x","article-title":"Evolving paradigms for repair of tissues by adult stem\/progenitor cells (MSCs)","volume":"14","author":"Prockop","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.mayocp.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","article-title":"A\u00a0phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy","volume":"12","author":"Forbes","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.mayocp.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.mayocp.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/MIB.0b013e31827f27df","article-title":"Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn's disease: a phase 1 study","volume":"19","author":"Mayer","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/TP.0b013e3181a9f0a7","article-title":"Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model","volume":"88","author":"Wei","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.mayocp.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/cdd.2009.187","article-title":"Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis","volume":"17","author":"S\u00e9mont","year":"2010","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.mayocp.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL-15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616300040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616300040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T05:40:21Z","timestamp":1654753221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619616300040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0025619616300040"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.03.001","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}